Business Context and Reporting Period
This Form 8-K Current Report was filed by Principal Financial Group, Inc. on January 31, 2022. The filing details a significant reinsurance transaction involving Principal Life Insurance Company (PLIC) and Principal Reinsurance Company of Vermont (PRCV) with Sutton Cayman, Ltd., an affiliate of Talcott Resolution Life, Inc.
Key Financial Metrics and Transaction Details
- Transaction Type: 100% coinsurance cessions and retrocessions on a funds withheld basis.
- Assets Ceded: In-force U.S. retail fixed annuity and universal life insurance with secondary guarantee (ULSG) blocks.
- Ceding Commission: $189,000,000 payable to the Purchaser.
- Expected Proceeds: Approximately $800 million in deployable proceeds upon closing.
- Share Repurchase Authorization: Increased by $1.6 billion to a total of $2.7 billion available.
- 2022 Repurchase Target: Increased from $800 million-$1.0 billion to $2.0 billion-$2.3 billion.
Material Changes and Strategic Actions
The company entered into a Master Transaction Agreement (MTA) to cede specific life insurance blocks to improve capital efficiency. While Principal retains administration of the ceded business, Principal Global Investors, LLC will serve as the investment advisor for transferred commercial mortgage loans and private credit assets. The transaction includes counterparty protections such as supplemental trust arrangements for overcollateralization and restrictions on the release of proceeds if the Purchaser fails to meet risk-based capital targets.
Guidance, Outlook, and Risks
The transaction is anticipated to close in the second quarter of 2022, with economics effective as of January 1, 2022. The filing notes that the share repurchase program is subject to market conditions and there is no assurance regarding the timing or final terms of repurchases. Forward-looking statements regarding expected proceeds and closing dates are subject to risks and uncertainties, including the requirement for regulatory approvals.
Key Facts for Investor Verification
- Confirmation of regulatory approvals required for the reinsurance transaction to close in Q2 2022.
- Verification of the $800 million deployable proceeds impact on the company's balance sheet.
- Monitoring of the execution of the increased $2.0 billion-$2.3 billion share repurchase target for 2022.
- Assessment of the $189 million ceding commission impact on near-term earnings.
- Review of the specific risk-based capital targets and overcollateralization terms protecting the Principal Insurers.